APOPTOSIS REGULATOR BAX
HOMO SAPIENS
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 1–171 Chain B; UniProt 1–171 | Fragment:RESIDUES 1-171 Mutation:YES | PR PRASEODYMIUM ION × 2 CL CHLORIDE ION × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3 | Resolution 2.80 Å R-free 0.274 |
| 2 | Protein homooligomer Homooligomer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain C; UniProt 1–171 Chain D; UniProt 1–171 | Fragment:RESIDUES 1-171 Mutation:YES | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3 | Resolution 2.80 Å R-free 0.274 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 4BD7 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1F16 SOLUTION STRUCTURE OF A PRO-APOPTOTIC PROTEIN BAX Deposited 2000-05-18 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–192(192 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6;305 K;Ionic strength (raw mmCIF value) 10 mM;Pressure AMBIENT
NMR sample composition
1MM BAX U-15N,13C; 10mM TRIS-ACETATE PH 6.0 2MM DTT
|
Resolution not provided |
| 2K7W BAX Activation is Initiated at a Novel Interaction Site Deposited 2008-08-27 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–192(192 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6;305 K;Ionic strength (raw mmCIF value) 50;Pressure ambient
NMR sample composition
0.1-0.2 mM [U-99% 15N] protein, 0.1-0.2 mM peptide, 90% H2O/10%D20 | 90% H2O/10%D20
|
Resolution not provided |
| 2LR1 Structural Mechanism for Bax Inhibition by Cytomegalovirus Protein vMIA Deposited 2012-03-20 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–192(192 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.2;310 K;Ionic strength (raw mmCIF value) 50;Pressure ambient
NMR sample composition
0.1 mM protein_1, 0.1 mM [U-100% 13C; U-100% 15N] protein_2, 20 mM potassium phosphate, 5 M [U-100% 2H] D2O, 50 M H2O, DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.1 mM [U-100% 15N] protein_1, 0.1 mM protein_2, 20 mM potassium phosphate, 5 M [U-100% 2H] D2O, 50 M H2O, DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 3PK1 Crystal structure of Mcl-1 in complex with the BaxBH3 domain Deposited 2010-11-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
48–81(34 aa)
Fragment:BH3 domain, UNP residues 48-81
|
Not recorded | CD CADMIUM ION × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;1M Sodium Acetate, 0.1M Hepes, 25mM Cadmium Sulfate, 5mM TCEP, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.49 Å R-free 0.245 |
| 3PK1 Crystal structure of Mcl-1 in complex with the BaxBH3 domain Deposited 2010-11-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
48–81(34 aa)
Fragment:BH3 domain, UNP residues 48-81
|
Not recorded | CD CADMIUM ION × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;1M Sodium Acetate, 0.1M Hepes, 25mM Cadmium Sulfate, 5mM TCEP, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.49 Å R-free 0.245 |
| 3PL7 Crystal structure of Bcl-xL in complex with the BaxBH3 domain Deposited 2010-11-14 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
48–81(34 aa)
Fragment:BH3 domain, UNP residues 48-81
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;293 K;13% Peg 6000, 0.2M CaCl2, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.61 Å R-free 0.249 |
| 4BD2 Bax domain swapped dimer in complex with BidBH3 Deposited 2012-10-04 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75
|
Resolution 2.21 Å R-free 0.227 |
| 4BD6 Bax domain swapped dimer in complex with BaxBH3 Deposited 2012-10-05 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain C
48–81(34 aa)
Fragment:RESIDUES 48-81
|
Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75
|
Resolution 2.49 Å R-free 0.285 |
| 4BD8 Bax domain swapped dimer induced by BimBH3 with CHAPS Deposited 2012-10-05 | Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain B
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES Mutation:YES | PR PRASEODYMIUM ION × 2 EDO 1,2-ETHANEDIOL × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3
|
Resolution 2.22 Å R-free 0.256 |
| 4BD8 Bax domain swapped dimer induced by BimBH3 with CHAPS Deposited 2012-10-05 | Different ligand/ion Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain D
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES Mutation:YES | EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3
|
Resolution 2.22 Å R-free 0.256 |
| 4BDU Bax BH3-in-Groove dimer (GFP) Deposited 2012-10-08 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
Chain B
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
|
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
10% PEG3350, 20% MPD, 0.5% CHAPS, 0.1 M TRIS PH 8.0
|
Resolution 3.00 Å R-free 0.246 |
| 4BDU Bax BH3-in-Groove dimer (GFP) Deposited 2012-10-08 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain C
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
Chain D
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
|
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
10% PEG3350, 20% MPD, 0.5% CHAPS, 0.1 M TRIS PH 8.0
|
Resolution 3.00 Å R-free 0.246 |
| 4S0O Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (I) Deposited 2015-01-02 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–192(192 aa)
Chain B
1–192(192 aa)
|
Mutation:P168G Mutation:P168G | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS , PH 6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
|
Resolution 1.90 Å R-free 0.265 |
| 4S0P Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (II) Deposited 2015-01-04 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–192(192 aa)
|
Mutation:G67R | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.25 Å R-free 0.270 |
| 4S0P Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (II) Deposited 2015-01-04 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
1–192(192 aa)
|
Mutation:G67R | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.25 Å R-free 0.270 |
| 4UF2 Deerpox virus DPV022 in complex with Bax BH3 Deposited 2014-12-23 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
50–77(28 aa)
Fragment:BH3, UNP RESIDUES 50-77
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;20% PEG 6000, 0.2M MES PH 6.0, 0,2M AMMONIUM SULPHATE.
|
Resolution 3.00 Å R-free 0.274 |
| 4ZIE Crystal Structure of core/latch dimer of Bax in complex with BimBH3 Deposited 2015-04-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–166(166 aa)
|
Mutation:C62S C126S | EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;277 K;PEG6000, bicine
|
Resolution 1.80 Å R-free 0.229 |
| 4ZIF Crystal Structure of core/latch dimer of Bax in complex with BimBH3mini Deposited 2015-04-28 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–166(166 aa)
|
Mutation:C62S C126S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.40 Å R-free 0.255 |
| 4ZIG Crystal Structure of core/latch dimer of Bax in complex with BidBH3mini Deposited 2015-04-28 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–166(166 aa)
|
Mutation:C62S, C126S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.20 Å R-free 0.229 |
| 4ZIH Crystal Structure of core/latch dimer of Bax in complex with BimBH3mini Deposited 2015-04-28 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–164(164 aa)
|
Mutation:C62S, C126S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.50 Å R-free 0.233 |
| 4ZII Crystal Structure of core/latch dimer of BaxI66A in complex with BidBH3 Deposited 2015-04-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–170(170 aa)
|
Mutation:C62S, C126S | EDO 1,2-ETHANEDIOL × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, sodium cacodylate
|
Resolution 2.19 Å R-free 0.223 |
| 5W5X Crystal structure of BAXP168G in complex with an activating antibody Deposited 2017-06-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G | EDO 1,2-ETHANEDIOL × 9 ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 4000, HEPES
|
Resolution 2.50 Å R-free 0.243 |
| 5W5X Crystal structure of BAXP168G in complex with an activating antibody Deposited 2017-06-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G | EDO 1,2-ETHANEDIOL × 18 ZN ZINC ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 4000, HEPES
|
Resolution 2.50 Å R-free 0.243 |
| 5W5Z Crystal structure of BAXP168G in complex with an activating antibody at high resolution Deposited 2017-06-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
32–192(161 aa)
Fragment:UNP residues 32-192
|
Mutation:C62S C126S P168G | EDO 1,2-ETHANEDIOL × 3 PG4 TETRAETHYLENE GLYCOL × 2 PGE TRIETHYLENE GLYCOL × 2 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Peg4000, MES
|
Resolution 2.00 Å R-free 0.268 |
| 5W60 Crystal structure of BAXP168G monomer cryo-protected with ethylene glycol Deposited 2017-06-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, TRIS
|
Resolution 1.80 Å R-free 0.238 |
| 5W61 Crystal structure of BAXP168G monomer co-crystallized with glycerol Deposited 2017-06-16 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, bis-TRIS, glycerol
|
Resolution 2.30 Å R-free 0.252 |
| 6EB6 Crystal structure of BAX W139A monomer Deposited 2018-08-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–192(192 aa)
|
Mutation:W139A | FMT FORMIC ACID × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Sodium formate, TCEP
|
Resolution 2.02 Å R-free 0.201 |
| 6L8V membrane-bound Bax helix2-helix5 domain Deposited 2019-11-07 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Mutation:C62S, C126S Mutation:C62S, C126S | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6;305 K;Ionic strength (raw mmCIF value) 100;Pressure 1
NMR sample composition
0.5 mM U-98% 15N;U-98% 13C;U-98% 2H human Bax core domain, 100 mM DMPC, 140 mM DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM U-98% 15N;U-98% 13C Bax a_2_a_5, 100 mM [U-2H] DMPC, 160 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM U-98% 15N;U-2H Bax a_2_a_5, 120 mM [U-2H] DMPC, 200 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM U-98% 15N;U-2H Bax a_2_a_5, 100 mM DMPC, 160 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM U-98% 15N;U-15% 13C Bax a_2_a_5, 80 mM DMPC, 140 mM DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM U-98% 13C Bax a_2_a_5, 120 mM [U-2H] DMPC, 200 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 6L95 transmembrane-domain of Bax Deposited 2019-11-08 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
166–192(27 aa)
Chain B
166–192(27 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.5;298 K;Ionic strength (raw mmCIF value) 150;Pressure 1
NMR sample composition
0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM [U-98% 15N;U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.3 mM [U-98% 15N;U-2H] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM [U-98% 15N;U-15% 13C] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.3 mM [U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 6TRR Structural insight into tanapoxvirus mediated inhibition of apoptosis Deposited 2019-12-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
50–77(28 aa)
|
Not recorded | NA SODIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium Chloride, 0.1 M Citrate pH 4.0
20% PEG 6000
|
Resolution 2.12 Å R-free 0.254 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain J
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain L
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 7 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain N
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 6XY6 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain P
50–77(28 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å R-free 0.288 |
| 7ADT Orf virus Apoptosis inhibitor ORFV125 Deposited 2020-09-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
50–77(28 aa)
Chain U
50–77(28 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 7 GOL GLYCEROL × 2 MG MAGNESIUM ION × 41 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Bis-Tris pH 5.5, 25% PEG 3350
|
Resolution 2.21 Å R-free 0.259 |
| 8G1T Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21 Deposited 2023-02-02 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å R-free 0.248 |
| 8G1T Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21 Deposited 2023-02-02 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å R-free 0.248 |
| 8G1T Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21 Deposited 2023-02-02 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain E
53–128(76 aa)
Chain F
53–128(76 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å R-free 0.248 |
| 8G1T Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21 Deposited 2023-02-02 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain G
53–128(76 aa)
Chain H
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å R-free 0.248 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded | ZN ZINC ION × 4 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain Q
53–128(76 aa)
Chain R
53–128(76 aa)
Chain S
53–128(76 aa)
Chain T
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain G
53–128(76 aa)
Chain H
53–128(76 aa)
Chain U
53–128(76 aa)
Chain V
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
53–128(76 aa)
Chain F
53–128(76 aa)
Chain I
53–128(76 aa)
Chain J
53–128(76 aa)
|
Not recorded | ZN ZINC ION × 2 EDO 1,2-ETHANEDIOL × 3 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain K
53–128(76 aa)
Chain L
53–128(76 aa)
Chain M
53–128(76 aa)
Chain N
53–128(76 aa)
|
Not recorded | ZN ZINC ION × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain O
53–128(76 aa)
Chain P
53–128(76 aa)
Chain W
53–128(76 aa)
Chain X
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 7 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain Y
53–128(76 aa)
Chain Z
53–128(76 aa)
Chain a
53–128(76 aa)
Chain b
53–128(76 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 8 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain c
53–128(76 aa)
Chain d
53–128(76 aa)
Chain e
53–128(76 aa)
Chain f
53–128(76 aa)
|
Not recorded | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPE Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31 Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 9 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain g
53–128(76 aa)
Chain h
53–128(76 aa)
Chain i
53–128(76 aa)
Chain j
53–128(76 aa)
|
Not recorded | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å R-free 0.256 |
| 8SPF Crystal structure of Bax core domain BH3-groove dimer - hexameric fraction with 2-stearoyl lysoPC Deposited 2023-05-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
Chain E
53–128(76 aa)
Chain F
53–128(76 aa)
|
Not recorded | 1GP SN-GLYCEROL-1-PHOSPHATE × 1 EDO 1,2-ETHANEDIOL × 5 OCT N-OCTANE × 1 D12 DODECANE × 1 DD9 nonane × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Hepes pH 7.5, 1.4 M trisodium citrate
|
Resolution 2.20 Å R-free 0.305 |
| 8SPZ Crystal structure of Bax core domain BH3-groove dimer - hexameric fraction with dioctanoyl phosphatidylserine Deposited 2023-05-04 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.09 M DL maleate-MES-Tris pH 7, 2.25 M ammonium sulfate, 0.1 M trisodium citrate
|
Resolution 2.40 Å R-free 0.341 |
| 8SPZ Crystal structure of Bax core domain BH3-groove dimer - hexameric fraction with dioctanoyl phosphatidylserine Deposited 2023-05-04 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.09 M DL maleate-MES-Tris pH 7, 2.25 M ammonium sulfate, 0.1 M trisodium citrate
|
Resolution 2.40 Å R-free 0.341 |
| 8SRX Crystal structure of BAK-BAX heterodimer with lysoPC Deposited 2023-05-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded | K6G [(2~{R})-2-oxidanyl-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] hexadecanoate × 3 ZN ZINC ION × 1 NA SODIUM ION × 2 PEG DI(HYDROXYETHYL)ETHER × 2 EDO 1,2-ETHANEDIOL × 2 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;281 K;0.1 M Bis-tris chloride pH 5.5, 25% PEG 3350, 200 mM sodium acetate
|
Resolution 2.09 Å R-free 0.265 |
| 8SRY Crystal structure of BAK-BAX heterodimer with C12E8 Deposited 2023-05-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded | PG0 2-(2-METHOXYETHOXY)ETHANOL × 1 PEG DI(HYDROXYETHYL)ETHER × 2 N8E 3,6,9,12,15-PENTAOXATRICOSAN-1-OL × 1 P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL × 1 PG4 TETRAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;281 K;30% PEG MME 2000, 0.1 M potassium thiocyanate, 0.01% C12E8
|
Resolution 2.40 Å R-free 0.248 |
| 8SVK Crystal structure of Bax D71N core domain BH3-groove dimer Deposited 2023-05-16 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Mutation:C62S, D71N, C126S Mutation:C62S, D71N, C126S | PEG DI(HYDROXYETHYL)ETHER × 2 PGE TRIETHYLENE GLYCOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium citrate, 20% PEG 3350
|
Resolution 2.25 Å R-free 0.287 |
| 8SVK Crystal structure of Bax D71N core domain BH3-groove dimer Deposited 2023-05-16 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Mutation:C62S, D71N, C126S Mutation:C62S, D71N, C126S | PEG DI(HYDROXYETHYL)ETHER × 1 PGE TRIETHYLENE GLYCOL × 1 PG4 TETRAETHYLENE GLYCOL × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium citrate, 20% PEG 3350
|
Resolution 2.25 Å R-free 0.287 |
| 9IXU Overall reconstruction of the Bax line Deposited 2024-07-29 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
1–192(192 aa)
Chain B
1–192(192 aa)
Chain C
1–192(192 aa)
Chain D
1–192(192 aa)
Chain E
1–192(192 aa)
Chain F
1–192(192 aa)
Chain G
1–192(192 aa)
Chain H
1–192(192 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.19 Å |
35 other PDB entries and 60 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | BAX_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–171; UniProt 1–171 Author chain B; PDBConstruct 1–171; UniProt 1–171 Author chain C; PDBConstruct 1–171; UniProt 1–171 Author chain D; PDBConstruct 1–171; UniProt 1–171 |